EPI-589 structure
|
Common Name | EPI-589 | ||
---|---|---|---|---|
CAS Number | 1147883-03-1 | Molecular Weight | 265.30 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C14H19NO4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of EPI-589EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS)[1]. |
Name | EPI-589 |
---|
Description | EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS)[1]. |
---|---|
Related Catalog | |
Target |
IC50: oxidoreductase enzyme[1] |
In Vivo | EPI-589 exhibits a significant improvement in cerebrospinal fluid (CSF) and plasma-based biomarkers known to be associated with neuroinflammation and ALS disease progression[2]. |
References |
[1]. BioElectron’s EPI-589 Shows Positive Results in ALS Patients in Phase 2a Trial [2]. Phase IIa trial of EPI-589 in ALS shows improvement in CSF |
Molecular Formula | C14H19NO4 |
---|---|
Molecular Weight | 265.30 |